Frazier Life Sciences Management, L.P.
CIK: 0001892134SEC EDGAR →
Portfolio Value
$3.7B
Holdings
40
As of
Q4 2025
New Positions
5
Closed Positions
12
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | 16,943,774 | $594.4M | 15.96% |
| 2 | MIRUM PHARMACEUTICALS INC | 6,795,121 | $536.7M | 14.42% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $286.8M | 7.70% |
| 4 | BRIDGEBIO PHARMA INC | 3,545,557 | $271.2M | 7.28% |
| 5 | MBX BIOSCIENCES INC | 6,652,013 | $209.8M | 5.64% |
| 6 | PHATHOM PHARMACEUTICALS INC | 12,466,489 | $206.8M | 5.55% |
| 7 | MAZE THERAPEUTICS INC | 4,567,274 | $189.2M | 5.08% |
| 8 | TREVI THERAPEUTICS INC | 10,259,409 | $128.4M | 3.45% |
| 9 | KRYSTAL BIOTECH INC | 488,460 | $120.4M | 3.23% |
| 10 | DISC MEDICINE INC | 1,260,000 | $100.1M | 2.69% |
Quarterly Changes
New Positions (5)
Closed Positions (12)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 39 | $3.7B | 98.4% |
| Unknown | 1 | $59.5M | 1.6% |